Sulfasalazine Market Primed for Growth owing to Increasing Demand of Rheumatoid Arthritis Treatment
Sulfasalazine Market Trends |
The sulfasalazine market has witnessed significant growth
over the past few years owing to increasing prevalence of autoimmune and
inflammatory diseases globally. Sulfasalazine is an anti-inflammatory drug used
primarily in the treatment of rheumatoid arthritis and inflammatory bowel
disease. It works by reducing inflammation and pain in joints and bowel. The
drug is available in delayed-release tablets and powder form for oral
administration. Its advantages over other anti-inflammatory drugs include
minimal side effects, low cost, and prolonged disease remission.
The global sulfasalazine market is
estimated to be valued at US$ 2.32 Bn in 2024 and is expected to exhibit a CAGR
of 18.% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the sulfasalazine market are Ophthotech Corporation,
Aptamer Sciences, Inc., Novartis AG, NeoNeuro SAS, Aptagen LLC, Aptus Biotech
S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies, Vivonics Inc., CAGE
Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca, GlyTech, Inc., GC Biopharma
Corp., Achiko AG, Agilent Technologies, Inc., SomaLogic Operating Co., Inc.,
Amsbio, and IVERIC bio, Inc.
The key opportunities in the Sulfasalazine
Market Trends include development of new delivery mechanisms to improve
patient compliance and investments in research & development of
sulfasalazine drug for new therapeutic indications.
Growing at a robust rate, the sulfasalazine market is expected witness global
expansion aided by increasing per capita healthcare spends in emerging
economies, entry of generic players, and strategic expansions by major brands.
Market Drivers
The primary driver boosting the growth of sulfasalazine market is rising
prevalence of rheumatoid arthritis globally. As per estimates, nearly 1% of the
worldwide population suffers from RA. Sulfasalazine is one of the first line
prescriptions for treatment of mild to moderate cases of RA. Growing geriatric
population susceptible to orthopedic diseases is another factor fueling the
demand. Moreover, increasing healthcare access and affordable substitution of
branded drugs by low cost generics in developing countries will significantly
contribute to market revenues during forecast period.
PEST Analysis
Political: Regulations related to drug approval processes and intellectual
property rights could impact the Sulfasalazine
Market Size and Trends. Stringent norms and protection of patented
drugs may influence industry dynamics.
Economic: Factors such as GDP growth, healthcare spending, and reimbursement
scenarios determine the uptake of sulfasalazine drugs. Macroeconomic
fluctuations impact spending abilities of patients.
Social: Growing awareness about inflammatory diseases and their treatment
options influence market trends. Adoption rates depend on social perceptions of
new drugs.
Technological: Advancements in drug delivery mechanisms, diagnostic techniques,
and manufacturing practices support product innovation. Collaborations for
development of combination therapies aid market progress.
Geographical Regions with High Market Concentration
North America accounts for a major share due to the region’s advanced
healthcare infrastructure and high spending capability. Access to quality
treatment drives the regional market.
Fastest Growing Region
Asia Pacific shows rapid expansion led by China and India on account of rising
disease prevalence, improving accessibility and affordability of therapies.
Initiatives to strengthen economic conditions contribute to regional market
growth.
Get More
Insights on- Sulfasalazine
Market
About
Author:
Ravina
Pandya, Content
Writer, has a strong foothold in the market research industry. She specializes
in writing well-researched articles from different industries, including food
and beverages, information and technology, healthcare, chemical and materials,
etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
Post a Comment